The Extract of Green Tea on Obese Women: a Randomized Double Blindness Clinical Trial

Taipei City Hospital

Status and phase: Completed; Phase 3

Conditions: Obesity

Treatments: Drug: the extract of green tea

Study type: Interventional

Funder types: Other

Identifiers

NCT00383058

NSC-95-2320-B-192-001

TH-Greentea-06-01

Details and patient eligibility

About

The purpose of this study is to examine whether the extract of the green tea is effective on obese women.

Full description

We conducted the pilot study in 2005. The initial findings showed the extract of green tea is benefit on obese women. The potential benefit include appetite lowing, lipid markers decreasing and regulating balance of obese related hormone peptides. So we designed this trial.

Sex: Female

Ages: 16 to 60 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

1. Age 16-60 years old female
2. BMI>27㎞/m2
3. Signed informed consent

Exclusion criteria

1. Endocrine disease, e.g. thyroid disorder, pituitary disorder, and sex gland disorder.
2. Heart disease, e.g. arrhythmia, heart failure, myocardial infarction, and patient with pacemaker.
3. Allergy and Immunology disease.
4. High aminotransferases ( Alanine, Aspartate >80 IU/L) or high serum Creatinine (>2.5 mg/dL)
5. Pregnant or lactating women.
6. Childbirth within 6 months.
7. Stroke or otherwise unable to exercise
8. Management for weight control within 3 months.
9. Any other conditions deemed unsuitable for trial as evaluated by the physician-in-charge.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind